PainChek
- Company typePublic
- Founded2016
- HeadquartersSydney, Australia
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
PainChek firmographics
Firmographics- Name
- PainChek
- Legal name
- PainChek Limited
- Website
- https://painchek.com
- Company type
- Public
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
PainChek industry classification
Industry- Product category
- Clinical pain assessment software
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF)
- akta.pro secondary industry
- SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
Keywords
Where PainChek is headquartered
LocationHeadquarters
- HQ city
- Sydney
- HQ country
- Australia
- HQ region
- Oceania
Offices4 records
Markets served
PainChek business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Per-Bed License Fees: Annual recurring license fees charged per bed in aged care facilities. In the US market, pricing is set at $55-75 USD per bed per annum under perpetual agreement with Sabra Health Care REIT.
- UK License Revenue: Contracted licenses in UK aged care market generating approximately A$230,000 in annual recurring revenue from 4,000 new contracted licenses (9% quarterly growth).
- RTM Reimbursement: Remote Therapeutic Monitoring reimbursement claims through US Centers for Medicare & Medicaid Services. Enables recurring revenue streams for technology-enabled pain assessment services.
- Professional Services: Training services, implementation support, and remote clinical onboarding provided as part of license agreements. Includes digital training via video conferencing and eLearning platform access.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | US Per-Bed Annual License |
| Subscription | Annual | UK License Contracts |
| Subscription | Annual | Enterprise Multi-Facility |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels7 records
PainChek product offering
Product offeringCore offering
PainChek develops and licenses AI-powered pain assessment software that uses smartphone-based facial recognition to detect pain in individuals who cannot reliably self-report, combined with five additional clinical assessment domains covering 42 indicators. The platform is delivered as a mobile app (PainChek Universal and PainChek Infant), a cloud analytics portal, and APIs that integrate with leading care management and medication management systems for residential aged care, home care, disability, hospital, and infant care providers.
Product overview
PainChek Universal is a unified AI-powered pain assessment platform combining a mobile application, analytics portal, and API data access. The core PainChek Universal platform uses AI facial recognition to assess pain in individuals who cannot reliably self-report (including those with dementia, cognitive impairments, or infants), while also including the Numeric Rating Scale for those who can communicate their pain. PainChek Analytics provides built-in data intelligence for clinical decision-making. The portfolio serves aged care, home care, disability, hospitals, and infant care sectors, integrating with leading care management and medication management systems across Australia, New Zealand, UK, Canada, and the US. The company holds 20+ million clinical assessments, FDA De Novo clearance (DEN240073), and operates across 1,900+ facilities globally.
Differentiator
Problem solved
Functional benefit
Products and services
- PainChek Universal AI-powered pain assessment platform for residential aged care, home care, disability, and hospital providers. Uses smartphone facial recognition to detect pain in individuals who cannot reliably self-report (including those with moderate to severe dementia) and includes a Numeric Rating Scale for self-reporting patients. Available on iOS and Android with cloud analytics.
- PainChek Infant AI-powered smartphone app for identifying likelihood of pain in infants aged 1-12 months. Helps parents and caregivers identify pain in babies who cannot communicate distress, tracks pain reliably, and supports informed care decisions. Available on iOS and Android.
- PainChek Analytics Cloud-based data intelligence portal that consolidates historical pain assessment data and provides real-time insights, trend analysis, monthly management dashboards, and predictive analytics for optimising pain management and clinical outcomes. Available to PainChek licensees at no extra cost.
Quantifiable outcome
- 42% reduction in falls in Scottish pilot
- +13 more outcomes
Companies that use PainChek
Customer profileNamed customers16 records
Segments5 records
Ideal customer profiles4 records
PainChek technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration21 records
AI capability6 records
Feature6 records
PainChek partnerships and signals
Strategic signalPartnerships
16 partnerships are on record, tiered flagship, core and minor.
- Sabra Health Care REITflagshipLandmark master services agreement to deploy PainChek's AI-powered pain assessment technology across up to 20,000 beds in 329 facilities across the US and Canada. Sabra is a Nasdaq-listed REIT with US$5 billion market cap. Pricing at US$55-75 per bed annually. First major entry into North American market.
- MED e-carecoreStrategic partnership with MED e-care's electronic medication management (eMAR) system to promote best practice pain management and address polypharmacy in UK care homes. Combines AI-driven pain assessment with medication monitoring.
- Eldermark SoftwarecorePartnership to expand US market by integrating PainChek with Eldermark's care management and EHR solutions for senior living facilities. Enables seamless adoption into US long-term care workflows.
- BESTMEDcorePartnership with BESTMED for medication management integration. Workflow improvements underway with medication management partners in Australia and NZ.
- Nourish CarecoreTwo-way integration with Nourish Care's app-based care planning platform, accredited by PRSB as Quality Partner. Enables pain assessment scores and observations to surface at point of care, supporting better decision-making and eliminating duplication.
- MPS ConnectcoreIntegration with MPS Connect's MediSphere medication management system for complete pain assessment and treatment in one software system. Supports aged care and home care markets.
- Nulsen GroupminorSix-month trial of PainChek in NDIS participants across five shared residential homes. First disability services partnership to validate pain detection in individuals with complex disabilities and behavioural challenges.
- Ramsay Hospital Research FoundationminorResearch partnership with Ramsay Health Care and Edith Cowan University to investigate ways of minimizing or stopping progression of frailty in hospital patients through better pain management using PainChek.
- Edith Cowan University (ECU)minorResearch partnership with Ramsay Hospital Research Foundation to lead consortium of 12 researchers investigating nurse-led volunteer support and optimal pain management through PainChek for frail hospital patients.
- PointClickCarecoreIntegration partnership enabling PainChek assessments to be surfaced within PointClickCare's care management platform. Key US market integration covering large segment of senior living facilities.
- YardicoreIntegration partnership to bring PainChek into Yardi's senior living technology workflows in the US market.
- CPR KidsminorPartnership with CPR Kids, a Certified Social Enterprise, for PainChek Infant app. Includes clinical review, co-development of parent and clinician education materials, and professional engagement activities.
- Edmonton GlobalminorPartnership for North American headquarters opening in Edmonton, Alberta. Supported by Edmonton Global economic development organization with Mayor and Alberta Health Ministers in attendance.
- Person Centred SoftwarecoreIntegration partnership with UK's largest digital care management platform. PainChek assessments automatically sent to care management system. When PainChek identifies pain, automatic 'must do' reassessment alert generated.
- AlayaCarecoreIntegration with AlayaCare's cloud-based home care software platform for Canadian market. Covers significant portion of aged care beds in Australia and supports international expansion.
- AscomcoreIntegration partnership with Ascom for UK market. New integration launched supporting pain data visibility in clinical workflows.
Scale indicators13 records
Recent moves8 records
Expansion highlights7 records
PainChek competitors and assessment
Company assessmentEmerging players
- Huma: Huma provides regulated remote patient monitoring and digital-health infrastructure for care organizations. It is comparable to PainChek through its regulated clinical data platform and provider workflow, although it addresses a broader set of conditions and biomarkers.
- SafelyYou: SafelyYou provides AI-enabled fall detection and care insights for senior living and dementia care. It serves many of the same care facilities and vulnerable populations as PainChek, but addresses fall management rather than pain identification.
- Binah.ai: Binah.ai uses camera-based AI to extract health-related measurements from video. It is technically comparable to PainChek through smartphone video analysis and health-data generation, but its core outputs are vital signs and wellness measurements rather than pain assessment.
- NuraLogix: NuraLogix develops contactless, camera-based health-measurement technology using signal analysis. Its AI extraction of health information from video is comparable to PainChek's imaging and multimodal analysis, although NuraLogix emphasizes general vital signs and chronic-disease risk.
- Best Buy Health (Current Health): Best Buy Health's Current Health business offers remote patient monitoring through connected devices and a clinical platform. It is comparable through remote monitoring, longitudinal data, and home-based care, but focuses on physiological monitoring rather than facial and behavioral pain assessment.
Broad incumbents
- PointClickCare: PointClickCare is a major care-management and electronic-record platform for senior care providers. It is comparable through its aged-care customer base and workflow position, while also serving as a channel through which PainChek assessments can be surfaced.
- AlayaCare: AlayaCare is a home-care management and remote-monitoring platform used by aged-care providers. It is comparable because both companies target home-care organizations and embed data into caregiver workflows, and AlayaCare also acts as a PainChek integration partner.
- Hinge Health: Hinge Health is a scaled digital musculoskeletal pain-management platform combining technology-enabled exercise and coaching. It is comparable through its focus on measurable pain improvement, while its employer- and payer-oriented model and self-directed MSK treatment are broader than PainChek's caregiver-led assessment tool.
- Sword Health: Sword Health provides digital musculoskeletal care using remote clinicians, exercise therapy, and patient engagement technology. It shares PainChek's objective of using digital tools to improve pain management, but targets a narrower treatment pathway and different buyer set.
Direct peers
- PainDrainer: PainDrainer applies digital and AI-enabled tools to chronic-pain assessment and management. It is comparable to PainChek because both use technology to improve pain decisions, although PainDrainer is more patient-facing and PainChek is focused on professional caregivers and people unable to self-report.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
PainChek social profiles
Digital presencePainChek compliance and trust
Trust signalCompliance8 records
PainChek financial estimates
Financial estimateRevenue estimate
Valuation estimate
PainChek leadership team
Management profileNumber of profiles
Profiles14 records
PainChek subsidiaries and ownership
Company hierarchySubsidiaries3 records
PainChek funding detail
Funding detailFunding overview
Funding rounds3 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PainChek M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PainChek
What does PainChek do?
PainChek develops and licenses AI-powered pain assessment software that uses smartphone-based facial recognition to detect pain in individuals who cannot reliably self-report, combined with five additional clinical assessment domains covering 42 indicators. The platform is delivered as a mobile app (PainChek Universal and PainChek Infant), a cloud analytics portal, and APIs that integrate with leading care management and medication management systems for residential aged care, home care, disability, hospital, and infant care providers.
Is PainChek a public or private company?
PainChek is a public company. It is classified as public and is currently operating.
When was PainChek founded?
PainChek was founded in 2016. It employs 11 to 50 people.
Where is PainChek based?
PainChek is headquartered in Sydney, Australia, in the Oceania region.
How does PainChek make money?
Four revenue lines are on record. Per-Bed License Fees are the primary driver. The others are UK License Revenue, RTM Reimbursement and professional Services.
Who are PainChek's main competitors?
Emerging players on record are Huma, SafelyYou, Binah.ai, NuraLogix and Best Buy Health (Current Health). Broad incumbents are PointClickCare, AlayaCare, Hinge Health and Sword Health. PainDrainer is listed as a direct peer.
Does PainChek have an API?
Yes. Clinical leaders can access data via an API, enabling sophisticated analysis at organisational, facility, and individual level for both users and residents. Access is available to clients as part of their PainChek license. No public documentation, SDK, or developer portal specified.
What industry is PainChek in?
PainChek's product category is Clinical pain assessment software. Its primary akta.pro industry code is HLACANAF, SaMD – Digital Biomarkers & Algorithmic Endpoints, with a secondary code of HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML). Its SIC code is 8000.